University of Minnesota. Driven to Discover.
Study says this year's vaccine provided moderate protection against serious flu outcomes.
Ill patients in Liberia and Sierra Leone cause concern in what WHO calls 'rapidly evolving' Ebola outbreak.
Canadian scientists may have solved the mystery of low vaccine efficacy against the H3N2 strain.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.